Human telomerase reverse-transcriptase promoter-controlled and herpes simplex virus thymidine kinase-armed adenoviruses for renal cell carcinoma treatment

New treatment strategies are required for renal cell carcinoma (RCC) due to its relative insensitivity to conventional radio- and chemotherapies. The promising strategy of tumor inhibition using human telomerase reverse transcriptase (hTERT)-controlled herpes simplex virus thymidine kinase/ganciclov...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Dawei, Sun, Yan, Yang, Yang, Lei, Mingde, Ding, Na, Han, Ruifa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665657/
https://www.ncbi.nlm.nih.gov/pubmed/23723709
http://dx.doi.org/10.2147/OTT.S41978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665657/
https://www.ncbi.nlm.nih.gov/pubmed/23723709
http://dx.doi.org/10.2147/OTT.S41978

Ejemplares similares